143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Over 7 million US seniors have mental declines that threaten financial skills

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite
Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to
Early nerve intervention found to reduce pain and complications after amputation

Early nerve intervention found to reduce pain and complications after amputation

byWolters Kluwer HealthCredit: CC0 Public DomainPerformed early—at the time of amputation—a procedure called targeted muscle reinnervation (TMR) can reduce pain scores and prevent complications

Early nerve intervention found to reduce pain and complications after amputation

byWolters Kluwer HealthCredit: CC0 Public DomainPerformed early—at the time of amputation—a procedure called targeted muscle reinnervation (TMR) can reduce pain scores and prevent complications
New memory drug moves into Phase 1 clinical study

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
FDA approves Vyalev for advanced Parkinson's disease

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an
Obesity linked to neurodegeneration through insulin resistance

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th
New insight into role of amyloid beta in Alzheimer's disease

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul
Helping children and young people isolated by young onset dementia find a voice

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia

Helping children and young people isolated by young onset dementia find a voice

by University of SheffieldA pioneering study led by researchers from the University of Sheffield is helping to give a voice to children and young adults who are living with a parent with dementia
Psychological well-being at 52 years could impact on cognitive functioning at 69 years

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio

Psychological well-being at 52 years could impact on cognitive functioning at 69 years

by IOS PressCredit: CC0 Public DomainPeople around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commissio
Challenging assumptions on the economic costs of dementia

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in

Challenging assumptions on the economic costs of dementia

by Trinity College DublinPredicted average health-care cost per patient at diagnosis as well as 10 years before and 6 years after. 95% confidence intervals indicated by the whiskers. Expressed in